Protara Therapeutics, Inc. TARA
2.35 USD -0.06 (-2.49%)
At closeNov 4, 2026, 4:00 PM EST
2.26 -0.09 -3.83%
After hours · Nov 4, 4:00 PM ET
2.34 Day range 2.54
2.28 52-week range 7.82
- YTD
- -55.91%
- 1 year
- -49.35%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 26.40 +1023.4% upside
Now 2.35
- Target (low)
- 14.00
- Target (mean)
- 26.40
- Target (high)
- 50.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 4
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.54333 | -0.61 – -0.51 | -0.90 | +39.6% | 0 | 0.0% | 3 |
| Next quarter | -0.62 | -0.67 – -0.55 | -0.97 | +36.1% | 0 | 0.0% | 3 |
| Current year | -2.30 | -2.38 – -2.22 | -3.57 | +35.6% | 0 | 0.0% | 3 |
| Next year | -2.28 | -2.67 – -1.54 | -2.30 | +0.7% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 6, 2024 | Guggenheim | Reiterated | Buy | Buy |
| Dec 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 22, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 4, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 9, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Aug 10, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 9, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 8, 2021 | Oppenheimer | Maintained | — | Outperform |
| Jun 4, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 19, 2020 | Cowen & Co. | Initiated | — | Outperform |
| Jul 29, 2020 | Guggenheim | Initiated | — | Buy |